NCT06632327 2026-03-04
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
Alliance for Clinical Trials in Oncology
University of Oxford
AstraZeneca
University of Illinois at Chicago
Maia Biotechnology
Bristol-Myers Squibb
Intergroupe Francophone de Cancerologie Thoracique
Mario Negri Institute for Pharmacological Research
Gustave Roussy, Cancer Campus, Grand Paris
The Cleveland Clinic
City of Hope Medical Center